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This case highlights two very rare complications of metastatic colorectal carcinoma. It describes a 59 year old female with both
cutaneous and endometrial metastases from colorectal carcinoma. While both of these presentations are very unusual, they
highlight the need to be vigilant about the detection of metastatic complications during follow up.
1.Introduction
A previously well 59-year-old lady presented to her gastroen-
terologist with per rectal bleeding. Apart from intermittent
inhaled salbutamol for asthma, she takesno medications and
has no allergies. She is a lifelong nonsmoker and consumes
30g of alcohol per week. She has no family history of note.
Colonoscopy demonstrated a tumour at the rectosigmoid
junction (see Figure 1).
A staging CT of Chest/Abdomen/Pelvis revealed no
obvious distal metastatic disease. Anterior resection and
cholecystectomy was performed in June 2006 without
complication.Histopathologydemonstratedmoderatelywell
diﬀerentiatedrectosigmoid adenocarcinoma. Resectionmar-
gins were free of tumour. Both lymphatic and venous
invasionwerenoted;17of18regionallymphnodesincluding
theapicalgland containedmetastatic tumour.Shewas staged
as T3N2M0 (IIIb). She received adjuvant FOLFOX-6 (Flu-
orouracil, Oxaliplatin, bolus Fluorouracil, and Leucovorin)
forsixmonths.Fullcourseanddoseswereachievedwithonly
mild thrombocytopaenia.
Repeat CT scan at end of chemotherapy (January 2007)
demonstrated two 5mm lesions in the left lower lobe and
right middle lobe of the lung. While metastatic disease
could not be ruled out, the lesions were thought to be
granulomatous in nature. Two low attenuation areas were
identiﬁed in the liver posteromedially, measuring 8mm and
15mm in diameter. A para-aortic lymph node measured
6mm.
Progress CT in July 2007 demonstrated increase in the
para-aortic lymphadenopathy. Repeated 4 months later, a
new lobulated 5mm nodule was noted in periphery of
right upper lobe along with more extensive para-aortic
and left common iliac lymphadenopathy, suspicious of
recurrent disease. PET scanning demonstrated FDG avid
disease involving lymph node groups both above and below
the diaphragm, and in particular the left para-aortic chain.
CT conﬁrmed extensive left para-aortic lymphadenopathy
with more focal nodal masses posterior to left renal vein and
at common iliac bifurcation.
Aneedlebiopsyofthepara-aorticlymphnodeconﬁrmed
adenocarcinoma consistent with prior colonic primary.
She received a further 6-month course of FOLFOX-6
from 3/3/2008 to 6/8/2008; again achieving a good partial
responsewithresolutionoftheadenopathyandstabledisease
in the other measurable lesions.
In November 2008 the patient reported left leg lym-
phoedema. Progress imaging and Doppler Ultrasound of
legs revealed no new pathology. The oedema progressed and
spread to the thigh, with left iliac fossa tenderness felt at the
same time. CEA had increased to 8.8.
The patient developed per vaginal bleeding in January
2010. Pelvic ultrasound demonstrated a thin and regular
endometrium. CT showed no evidence of recurrence at2 ISRN Oncology
Figure 1: Original rectosigmoid adenocarcinoma.
surgical site, as well as decreased size of both right middle
lobe lung lesion and left external iliac lymph nodes. She was
referred for uterine curettage, performed in February 2010.
This demonstrated scanty disintegrating adenocarcinoma
cells inﬁltrating the lower uterine segment. The malignant
cells were positive for CK20 and negative for CK7, sup-
porting diagnosis of metastatic colonic carcinoma. P16 was
negativeandCEA/mucinstainswerediﬃculttointerpretdue
to degenerative changes.
She was referred for gynaecological assessment in Febru-
ary 2010. Per vaginal examination showed the uterus to have
a ﬁrm and nodular consistency.
Along with the PV bleeding, the patient reported right
upperbackpaininaradicularpatternfromthelowercervical
s p i n et ot h er i g h tp r o x i m a lh u m e r u s .T h e r ew a sn on e u r o -
logicaldeﬁcit.CTonsame dayshowed a destructive lesionin
C7 vertebral body on right side with pathological fracturing.
Whole body bone scan with SPECT 19/2/10 showed intense
abnormality in body C7 consistent with a metastatic lesion.
MRI of the spine 19/2/10 showed pathological superior
endplate fracture associated with metastatic deposit in the
C7 vertebral body. Some bone retropulsion into canal was
presentwithoutsigniﬁcant canalstenosis/cordimpingement.
Markedright-sided C8/T1foraminal stenosis was noted with
possible right C7 radicular impingement.
The patient commenced palliative radiotherapy to the
cervicalspinein 10fractions of30Gy.Shetoleratedthisfairly
well with minor dermatological reactions.
A dermatitic like eruption on left upper/inner thigh and
buttock was noted in April 2010, which did not respond
to treatment with topical steroids (see Figures 2 and 3).
She was reviewed by a dermatologist and punch biopsy of
left upper thigh was carried out on 28/4/10. This showed
multiple micronodules pleomorphic cells in superﬁcial and
mid dermis, showing focal ductular diﬀerentiation. The
biopsy was in keeping with metastatic adenocarcinoma (see
Figure 4).
She had 3 cycles of FOLFOX, however, this was poorly
tolerated due to anaphylactic reactions. She has since
commenced a combination of ﬂuorouracil, folinic acid, and
irinotecan.
Figure 2: Skin lesion.
Figure 3: Skin lesion.
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Figure 4: Histopathology of skin biopsy showingmultiple micron-
odules of pleomorphic cells with some tumour nodules within
lymphatic channels consistent with metastatic spread of colorectal
carcinoma.
2.Discussion
Colorectal cancer is the second most prevalent malig-
nancy in Australia (excluding nonmelanocytic skin cancers)
[1]. Approximately 20 percent of patients have distantISRN Oncology 3
metastatic disease at the time of presentation[2]. Carcinoma
can spread by lymphatic, haematogenous, contiguous and
transperitoneal routes. The most common metastatic sites
are the regional lymph nodes, liver, lungs, and peritoneum.
Consequently, patients may present with signs or symptoms
referable to these areas. There are recognized unusual
presentations of CRC. These include local invasion causing
malignant ﬁstula formation into adjacent organs, such as
bladder or small bowel. Fever of unknown origin, intra-
abdominal, retroperitoneal, or abdominal wall abscesses can
often be the ﬁrst manifestation.
CRC proves to be the aetiology in 6% of adenocarcino-
mas of unknown primary sites [3].
Our patient presented with spinal, endometrial, and
cutaneous involvement. These presentations are very rare
individually, however, there has beenno previouscase report
of a patient with both endometrial and cutaneous features.
Brandetal.reported aseries of6patientspresenting with
per vaginal bleeding in the setting of recurrent colon cancer
[4]. Only one of the patients in that series received adjuvant
chemotherapy prior to per vaginal bleeding. Despite aggres-
sive chemo-radiation or surgical management, all patients
had recurrence of colonic carcinoma.
Hu et al. found 124 cutaneous metastases from a series
of 12.146 patients with internal malignancies (1%) [5]. 16
of these cases originated from colorectal cancer, equating
to a rate of cutaneous metastasis of 0.81%. Other authors
have found rates of cutaneous metastasis between 2.3 and
6% [6–8]. Cutaneous metastases most often occur on a site
relatively close to the internal primary. Skin metastases from
the breast usually occur on the chest, the lung to the chest
and upper extremities, and the gastrointestinal tract to the
abdomen [9]. These metastases usually manifest as a rapidly
growing, mobile nodule [10]. On immunohistochemical
staining, CK20 positivity often correlates with colorectal
tumours [11].
This case highlights the importance of paying close
attention to symptoms and signs in patients with a past
history of internal malignancy. It is important to maintain
a high index of suspicion to clinical features that may
represent a metastatic process. Furthermore, tissue diagnosis
to conﬁrm the aetiology of a symptom can prove very useful,
as shown in this case.
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